Omega Therapeutics Stock Market Value
| OMGA Stock | USD 0.48 0.02 4.00% |
| Symbol | Omega |
Omega Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Therapeutics. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 1.812 | Return On Assets | Return On Equity |
The market value of Omega Therapeutics is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Omega Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Therapeutics' market value can be influenced by many factors that don't directly affect Omega Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Omega Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Omega Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Omega Therapeutics.
| 12/25/2024 |
| 01/24/2025 |
If you would invest 0.00 in Omega Therapeutics on December 25, 2024 and sell it all today you would earn a total of 0.00 from holding Omega Therapeutics or generate 0.0% return on investment in Omega Therapeutics over 30 days. Omega Therapeutics is related to or competes with Pmv Pharmaceuticals, MediciNova, Pharvaris, PepGen, Olema Pharmaceuticals, Nuvectis Pharma, and Larimar Therapeutics. Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company More
Omega Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Omega Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Omega Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 47.73 | |||
| Value At Risk | (10.47) | |||
| Potential Upside | 10.0 |
Omega Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Omega Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Omega Therapeutics' standard deviation. In reality, there are many statistical measures that can use Omega Therapeutics historical prices to predict the future Omega Therapeutics' volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.95) | |||
| Total Risk Alpha | (1.26) | |||
| Treynor Ratio | (3.91) |
Omega Therapeutics Backtested Returns
Omega Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.25, which implies the firm had a -0.25 % return per unit of risk over the last 3 months. Omega Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Omega Therapeutics' Variance of 48.54, coefficient of variation of (746.24), and Risk Adjusted Performance of (0.11) to confirm the risk estimate we provide. The company holds a Beta of 0.24, which implies not very significant fluctuations relative to the market. As returns on the market increase, Omega Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Omega Therapeutics is expected to be smaller as well. At this point, Omega Therapeutics has a negative expected return of -1.46%. Please make sure to check Omega Therapeutics' total risk alpha, kurtosis, price action indicator, as well as the relationship between the value at risk and rate of daily change , to decide if Omega Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.29 |
Weak reverse predictability
Omega Therapeutics has weak reverse predictability. Overlapping area represents the amount of predictability between Omega Therapeutics time series from 25th of December 2024 to 9th of January 2025 and 9th of January 2025 to 24th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Omega Therapeutics price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Omega Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Omega Therapeutics lagged returns against current returns
Autocorrelation, which is Omega Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Omega Therapeutics' stock expected returns. We can calculate the autocorrelation of Omega Therapeutics returns to help us make a trade decision. For example, suppose you find that Omega Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Omega Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Omega Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Omega Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Omega Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Omega Therapeutics Lagged Returns
When evaluating Omega Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Omega Therapeutics stock have on its future price. Omega Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Omega Therapeutics autocorrelation shows the relationship between Omega Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Omega Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Omega Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Therapeutics Stock:Check out Omega Therapeutics Correlation, Omega Therapeutics Volatility and Omega Therapeutics Alpha and Beta module to complement your research on Omega Therapeutics. For information on how to trade Omega Stock refer to our How to Trade Omega Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Omega Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.